{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T05:48:16Z","timestamp":1747892896403},"reference-count":8,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.schres.2007.02.005","type":"journal-article","created":{"date-parts":[[2007,4,15]],"date-time":"2007-04-15T07:12:35Z","timestamp":1176621155000},"page":"273-275","source":"Crossref","is-referenced-by-count":10,"title":["Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: An open-labeled trial"],"prefix":"10.1016","volume":"92","author":[{"given":"Zhang-Jin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Min","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Xing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2007.02.005_bib1","series-title":"The Scale for the Assessment of Positive Symptoms (SAPS)","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.schres.2007.02.005_bib2","first-page":"369","article-title":"Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy","volume":"31","author":"Ferreri","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2007.02.005_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2007.02.005_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-004-1794-x","article-title":"Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists","volume":"174","author":"Friedman","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2007.02.005_bib5","series-title":"ECDEU Assessment Manual for Psychopharmacology (Revised)","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2007.02.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1745-7254.2006.00255.x","article-title":"Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.schres.2007.02.005_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0091-3057(03)00111-4","article-title":"The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease","volume":"75","author":"Zangara","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2007.02.005_bib8","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.lfs.2004.04.014","article-title":"Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders","volume":"75","author":"Zhang","year":"2004","journal-title":"Life Sci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407001090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407001090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T05:41:46Z","timestamp":1556343706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996407001090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":8,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0920996407001090"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2007.02.005","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}